Ariosa says the sky is not falling, so Federal Circuit decision must stand

Ariosa Diagnostics has urged the US Court of Appeals for the Federal Circuit to reject Sequenom’s en banc request, stating that behind its “sky is falling” rhetoric is really a demand for courts to revise the US Supreme Court’s two-part test in determining the eligibility of a patent.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Sequenom’s en banc petition rejected by Federal Circuit

2 December 2015 The US Court of Appeals for the Federal Circuit has rejected Sequenom’s petition to re-hear its dispute with Ariosa Diagnostics en banc.

Americas

CAFC must end ‘existential threat’ to patents, argues Sequenom

19 August 2015 Sequenom has requested an en banc review of the US Court of Appeals for the Federal Circuit’s decision to invalidate one of its patents in its dispute with Ariosa Diagnostics, arguing that the decision creates an “existential threat” to patent protection.

Americas

Federal Circuit invalidates Sequenom patent, cites Mayo

17 June 2015 A US appeals court has affirmed that a patent covering the method of detecting foetal abnormalities in pregnant mothers is ineligible for protection because it applies to a “natural phenomenon”.

More on this story

Americas

Sequenom’s en banc petition rejected by Federal Circuit

2 December 2015 The US Court of Appeals for the Federal Circuit has rejected Sequenom’s petition to re-hear its dispute with Ariosa Diagnostics en banc.

Americas

CAFC must end ‘existential threat’ to patents, argues Sequenom

Americas

Federal Circuit invalidates Sequenom patent, cites Mayo

More on this story

Americas

Sequenom’s en banc petition rejected by Federal Circuit

2 December 2015 The US Court of Appeals for the Federal Circuit has rejected Sequenom’s petition to re-hear its dispute with Ariosa Diagnostics en banc.

Americas

CAFC must end ‘existential threat’ to patents, argues Sequenom

Americas

Federal Circuit invalidates Sequenom patent, cites Mayo